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Peri-operative monitoring technology has made great strides in the last 20 years with the introduction of
minimally invasive devices to measure inter alia stroke volume, cardiac output, depth of anaesthesia and
cerebral and tissue oxygen monitoring. Despite these technological advances, peri-operative manage-
ment of the high risk major surgery patient has remained virtually unchanged. The vast majority of
patients undergo a pre-operative assessment which is neither designed to quantify functional capacity
nor predict outcome. Anaesthetists then usually monitor these patients using the same technology (e.g.
pulse oximetry (SpO2), invasive systemic BP and CVP, end tidal carbon dioxide (etCO2) and anaesthetic
agent monitoring) that was available in the early 1980s. Conventional intra-operative management can
result in occult low levels of blood ﬂow and oxygen delivery that lead to complications that only occur
days or weeks following surgery and give false re-assurance to the anaesthetist that he or she is doing
a ‘‘good job’’. Post-operative management then often takes place in an environment with reduced levels
of both monitoring equipment and staff expertise. It is perhaps not surprising that outcome still remains
poor in high-risk patients.1
In this review, we will brieﬂy describe the role of peri-operative optimization, some of the available
monitors and indicate how their combined use might be beneﬁcial in managing the high-risk surgical
patient. We believe that although there is now evidence to suggest that the use of individual new
monitors (such as assessment of ﬂuid status, depth of anaesthesia, tissue oxygenation and blood ﬂow)
can inﬂuence outcome, it will only be their combination that will radically improve the peri-operative
management and outcome of high-risk surgical patients. It is a matter of some urgency that large scale,
prospective and collaborative studies be designed, funded and executed to prove or disprove this
hypothesis.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Deﬁnition
Advanced monitoring in the context of this review means
a combinedprocessof identiﬁcationandmanagementof thehigh risk
surgical patient throughout the peri-operative period using a set of
parameters, protocols and user interfaces that facilitate assessment
and optimization of anaesthesia, ﬂuids and drugs on the major
determinants of adequacy of oxygen delivery (DO2), oxygen utiliza-
tion, stroke volume (SV) and cardiac output (CO) including preload,
after load, heart rate and contractility as well as tissue oxygenation.
2. Pre-operative
Much work and energy have been expanded on optimizing the
high-risk surgical patient pre-operatively to usually very good effect.2ciates Ltd. Published by Elsevier LtHowever it is now generally recognized that it is not cost effective to
admitallpatients pre-operatively to ahighdependencyenvironment,
especially if this high quality of care is not then scrupulously main-
tained in the intra-operative and post-operative period.3
Cardiopulmonary exercise testing (CPET) is increasingly being
used in the pre-operative period to either exclude patients from
major surgery if their anaerobic threshold and maximum oxygen
delivery does not exceed pre-deﬁned (and arbitrary) parameters or
to distinguish patients who may need high dependency post-oper-
ativemanagement from those that will not.4–7 However, despite the
enthusiasm in some quarters, there is surprisingly little data to
support this form of triage in the form of randomized, controlled
trials, althougha recent systematic review identiﬁedbeneﬁt in some
patients, e.g. those undergoing open aortic aneurysm repair.8 The
pitfalls and limitations have been the subject of a recent editorial.9
Indeed, there is little evidence to support the contention that
major surgery is necessarily associated with or requires an increase
in oxygen delivery and consumption in the post-operative period.d. All rights reserved.
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which oxygen delivery and cardiac output were not optimized
intra-operatively.10–13 Thus, the increase in oxygen delivery and
consumption seen post-operatively may simply reﬂect the accu-
mulation of an intra-operative oxygen debt and may not occur if
DO2 is optimized intra-operatively. In the vast majority of trials of
intra-operative optimization of ﬂuid input (see later), measurement
of stroke volume and cardiac output have only been initiated
following induction of anaesthesia and thus the pre-operative CO is
not known. In our experience of over 200 cases of intra-operative
CO monitoring initiated prior to induction, there have been rela-
tively few cases where CO has increased substantially above pre-
operative levels during the procedure (suggesting increased oxygen
demand) despite optimization of depth of anaesthesia and protocol
driven ﬂuid management.
Indeed, if CO and DO2 are optimized intra-operatively, the
requirement to markedly increase CO and DO2 in the post-opera-
tive period (on which pretext the value of CPET testing as
a predictor of outcome depends) may only occur in patients who
are either genetically predisposed to have a marked inﬂammatory
response to surgery or in those who suffer a post-operative
complications and become septic.14
3. Intra-operative period
3.1. Fluid management optimization
Intra-operative ﬂuid management regimens have been the
subject of a number of recent excellent editorials and reviews
which have cast increasing doubt on the conventional intra-oper-
ative regimens used in intensive care and during major surgery.15–
18 In most cases, ﬂuids are still administered during intra-abdom-
inal surgery according to pre-determined ‘‘high volume’’ ﬂuid
regimens (such as 5–15 ml kg1 per hour of Hartmann’s/Lactated
Ringer’s solution) based on the presumed ‘‘third space’’ ﬂuid deﬁcit
that is ‘‘obligatory’’ during major intra-abdominal surgery.19 There
has thus been a presumption for nearly 50 years that patients
become relatively hypovolaemic during surgery unless these so
called ‘‘third space’’ losses are assiduously replaced. Indeed, in
a recent pilot study for a major trial of ﬂuid optimization in patients
undergoing colorectal surgery using oesophageal Doppler moni-
toring (ODM, Deltex Cardio Q (DCQ), Deltex Medical, Chichester,
UK), the intervention group was scheduled to receive, as a matter of
course, 1 L of Hartmann’s solution per hour, i.e. approximately
15 ml kg1 h1.20
However, recent trials have cast doubt on these ‘‘high volume’’
ﬂuid regimens, even suggesting that ﬂuid restriction may be
beneﬁcial,21,22 especially in thoracic and hepatic surgery. In our
experience, the additional amount (i.e. excluding blood loss, urine
output and insensible loss) of crystalloid necessary tomaintain pre-
deﬁned cardiovascular parameters using the ODM, i.e. the average
‘‘third space’’ requirement, was only 3.5 ml per kg per hour with
a range of 0–15.23 It is now increasingly recognized that the amount
of ﬂuid administered should be individualized to the patient’s needs
and not pre-determined by some liberal or restrictive regimen.24
3.1.1. How to determine intra-operative ﬂuid requirements
Unfortunately, conventional intra-operative monitoring may
not predict accurately ﬂuid requirements.25 Since MAP is depen-
dent on both cardiac output (CO) and systemic vascular resistance
(SVR) it is not a good indicator of blood ﬂow and thus oxygen
delivery. Optimization of CVP has less predictive value in compar-
ison to other measures of ﬂuid responsiveness such as those
provided by the ODM25–27 and may be associated with more
complications.28 Despite this, some studies have still used CVPmeasurements to optimize ﬂuid input in a control group of
patients, sometimes with values as high as 12–15 mm Hg and
consider this to be ‘‘conventional practice’’.27 On the other hand,
recent randomized trials and meta-analyses have conﬁrmed that
intra-operative ﬂuid optimization using the ODM improves
outcome.26,27,29–31 Interestingly, many of these trials result in the
intervention group receiving more ﬂuid than the control group.
The emphasis should now be on individualized therapy and
predicting responders to ﬂuid and minimising unnecessary ﬂuid
administration. As mentioned, many intra-operative regimens
involve the administration of large quantities of balanced salt
solutions with no improvement in oxygen delivery but with the
potential for haemodilution, ﬂuid and Na þ overload.
Stroke volume variation (SVV) and pulse pressure variation
(PPV) have generally been shown to be much better predictors of
ﬂuid responders than CVP or PCWP.32–40 However, SVV (or PPV)
assessment can only be utilized in mechanically ventilated patients
with adequate tidal volumes.38 In addition the patient must be in
sinus rhythm. In a ﬂuid depleted patient the effect of an increase in
intrathoracic pressure will cause a greater variation in SV (high
SVV) due to the greater effect on venous return. However as ﬂuid
boluses are administered and the patient becomes ﬂuid repleted,
the SVV falls and by the time it is around 5–10% the patient is
considered to be ﬂuid optimized. Further ﬂuid administration at
this stage is less likely to produce an increase in SV. Thus, main-
taining SVV at the 5–10% levels ensures optimization of stroke
volume whilst at the same time reducing the risk of ﬂuid overload
and haemodilution. The use of the LiDCOrapid (LiDCO Ltd., Cam-
bridge, UK) in this context will be discussed later.
Other monitors which also derive SV and SVV from analysis of
the arterial waveform (versus the Doppler) are also useful in this
context, including the PiCCO (Pulsion, Munich, Germany) and Flo-
trac (Edwards Lifesciences, USA). The PiCCO is less useful in
anaesthesia versus the ICU as it conventionally relies on a femoral
arterial line. Earlier versions of the Flotrac software produced
a percentage error (in comparison to thermodilution) of greater
than the usually accepted limit of 30%.41 The software is now in its
third generation (v1.10) and even now problems may still be
experienced in certain groups of patients, for example in cirrhosis
and where there are rapid changes in haemodynamics. Indeed,
a recent trial where the Flotrac (v.1.07) was compared with the
ODM showed no correlation of SVV, as measure by the Flotrac
versus increase in SV indicated by the ODM in abdominal surgery.42
The reader is referred to an excellent recent review where all these
points are considered in more detail.43
3.1.2. How should this affect practice
As a result of these trials, the recently published British Guide-
lines on Intravenous Fluid Therapy for Adult Surgical Patients now
recommends ﬂow versus pressure monitoring to assess ﬂuid
requirements intra-operatively.44 It is interesting to note that the
Association of Anaesthetists of Great Britain and Ireland (AAGBI)
and the Royal College of Anaesthetists (RCA) were invited to
participate in drawing up these guidelines but declined. Indeed the
recent AAGBI publication of recommended standards of monitoring
during anaesthesia and recovery seems oblivious to most of the
recent publications on this subject.45
3.2. Depth of anaesthesia monitoring
3.2.1. Should it be used?
Although the jury is still out on whether brain function moni-
toring should be routinely used during anaesthesia,45,46 many of
the peri and post-operative complications associated with the
anaesthetic process today can be reduced by aiming for an optimal
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a growing body of evidence points to the beneﬁts of monitoring
depth of anaesthesia. Bispectral index monitoring (BIS, Aspect
Medical Systems, Mass., USA), the ﬁrst technology to be approved
by the US Food and Drug Administration for monitoring the effects
of anaesthetic drugs on the brain, has been shown to reduce the
total amount of anaesthetic agents administered and speed up
recovery post-operatively.47–49 Studies have suggested a link
between anaesthetic depth (represented by low intra-operative BIS
values) and mortality up to a year after the procedure.50 Too light
anaesthesia may also be detrimental and research suggests that BIS
can monitor this with good sensitivity.51 Although BIS levels have
been shown to rise (indicating increased risk of awareness) before
other physiological signs appear52 it is crucial to realize that all
currently available monitors need varying calculation times (e.g.
about 30 s with BIS) to indicate changes between different levels of
hypnosis.53 Thus it is imperative that the anaesthetist anticipate
surgical stimulation and deepen the anaesthesia prior to the
expected stimulus.
Patients monitored with BIS, including those in the B-Aware
large randomized controlled trial, were signiﬁcantly less likely to
report awareness compared to control groups.54,55 The recent B-
Unaware trial has seemingly produced conﬂicting results.56
However, this latter study has been criticized on the grounds that
the 2 patients who were aware using BIS monitoring both had
signiﬁcant data missing and the study was insufﬁciently pow-
ered.57,58 A follow up editorial in another journal59 failed to notice
these problems and thus there is a continuing feeling amongst
anaesthetists, especially in the UK, that depth of anaesthesia
monitoring produces no beneﬁt.60
It is our view that it is not a question whether depth of anaes-
thesiamonitoring should be used on all cases but whether there are
any cases where its use should be mandatory. For example, during
total intravenous anaesthesia there is neither the means to esti-
mate the concentration of anaesthetic agent in the blood nor to set
end tidal anaesthetic concentration alarm limits which may help to
reduce awareness.56 In addition, i.v. disconnection ormisplacement
of the tubing and cannula will lead to total failure of anaesthetic
delivery and awareness. Another group at high risk of excessively
light or deep anaesthesia is the elderly patient where intra-Fig. 1. BIS traces in 18 consecutive patients aged 80 or over undergoing induction and maint
between 40 and 60 in the majority of patients (authors’ data). The x axis is in minutes.operative hypotension is common and usually managed empiri-
cally (vide infra), taking place in the context of inadequate knowl-
edge of the depth of anaesthesia. Maintaining BIS levels between 40
and 60 will circumvent this problem and reduce the uncertainty
whilst at the same time hopefully improving long-term outcome.50
Indeed, evidence suggests that elderly patients may lose
consciousness at a higher BIS level than younger patients but the
signiﬁcance of this needs to be studied during surgery.61
Bearing in mind that anaesthetic drugs have signiﬁcant effects
on the cardiovascular system, it would seem futile to try and
maintain ‘‘normal’’ cardiovascular status using ﬂuid administration
and/or inotropic support to a patient intra-operatively when there
is no quantitative estimate of how deeply (or lightly) anaesthetized
the patient is. As shown in the following three ﬁgures, it is difﬁcult
to estimate depth of anaesthesia without a device monitoring brain
function.
Fig. 1 shows BIS traces in 18 consecutive patients over the age of
80 undergoing induction and maintenance of anaesthesia with
remifentanil and propofol. BIS levels are maintained between 40
and 60 in the majority of patients.
Fig. 2, on the other hand, shows BIS traces in a control group of
18 elderly patients (70 and above) undergoing anaesthesia (various
techniques but not TIVA) for major orthopaedic or abdominal
surgery under general anaesthesia where the BIS reading was
recorded but not available to the anaesthetist. The trial was to
assess the effect of depth of anaesthesia on post-operative cognitive
dysfunction. One can see that the majority of patients are outside
the usually accepted limits.
Fig. 3 shows the BIS traces of 18 elderly patients (aged 70 and
over) in the intervention arm of the trial where although exces-
sively high readings are avoided (some high readings indicate the
end of the operation) it has proved difﬁcult to avoid excessively low
readings in some patients.
3.3. Measurement of oxygen delivery (DO2)
Despite the fact that most studies have tried to optimize SV, CO
and thus DO2, most have not actually measured DO2. This requires
repeatedmeasurements of Hb and SaO2 as essential components of
arterial oxygen content, as well as cardiac output. A recent studyenance of anaesthesia with remifentanil and propofol (TIVA). BIS levels are maintained
Fig. 2. BIS traces in a control group of 18 elderly patients (70 and above) undergoing anaesthesia for major orthopaedic or abdominal surgery under general anaesthesia. The BIS
monitor was not visible to the anaesthetist. The x axis is in minutes.
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versus control although it is not clear how many patients achieved
the usually accepted threshold of 600 ml m2 DO2.27 Clearly,
massive ﬂuid administration to pre-determined and arbitrary
regimens and endpoints will cause signiﬁcant haemodilution and
thus an increase in cardiac output might be offset by an even bigger
decrease in oxygen carrying capacity. The recent availability of the
Masimo Radical 7 (Masimo Corporation, California, USA) with beat-
to-beat Hb and SpO2 estimation will allow real time assessment of
DO2 if used alongside continuous measurement of CO. In addition,
this monitor is able to analyze the beat-to-beat changes in
plethysmographic variability and produce an index (the PVI) which
may also prove very useful in assessing ﬂuid status.62Fig. 3. BIS traces of 18 elderly patients (aged 70 and over) in the intervention arm of the tr
minutes.3.4. Brain and tissue oxygen monitoring
Even if seemingly adequate DO2 is maintained, it may still be
insufﬁcient to provide adequate oxygenation for vital centres such
as the brain. This is best demonstrated by the falls observed in
cerebral oxygen saturation (rSO2) in anaemic elderly patients
undergoing major abdominal surgery using the Somanetics Cere-
bral Oximeter (SCO, Troy, Michigan, USA) where these changes are
only correctable by blood transfusion63 and there is also evidence
that correction of these declines may improve outcome in both
non-cardiac and cardiac surgery.64,65 A recent study of the effects of
monitoring rsO2 on post-operative cognitive dysfunction (POCD) in
cardiac surgery showed much poorer outcome in those patientsial. The BIS monitor was visible to the anaesthetist. See text for details. The x axis is in
0.0
2.0
4.0
6.0
8.0
10.0
12.0
14.0
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35
Minutes
m
pl 
0
1 
o
t 
d
e
t
c
e
r
r
o
c 
O
C
Remi average drop 1% (0 to 15%)
Prop  average drop 44%  (11 to 69%)
Fig. 4. Cardiac output changes in 18 pts aged 65 and above during induction and early maintenance period using remifentanil (to Ceff of 2–3 ng ml1) followed by propofol to BIS
target of 45 using the LiDCOrapid. Remifentanil was commenced at 0 min and propofol at 3 min. All starting cardiac outputs were standardised to 10 l pm at time zero so that the
data could be compared more easily. The average drop in CO was 44% with a range of 11–69%.
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had any detectable POCD if the rSO2 remained above 50%.66 It is
also interesting to note marked falls in cerebral oxygenation during
one lung surgery which occur in the absence of any change in
systemic oxygen saturation as measured by a pulse oximeter.67
Recent work has demonstrated that a reduction in hemoglobin
(Hb), such as found after blood donation or haemodilution, may
signiﬁcantly reduce maximum exercise capacity and cognitive
function and thus may in itself be detrimental in the post-operative
period.68,69 The authors view is that we have become too blase´Fig. 5. The LiDCOrapid display (for full explanaabout the adverse effects of haemodilution, especially in the
elderly, and there is now evidence that we should transfuse if
cerebral saturation decreases signiﬁcantly. However, this view
remains controversial.
4. Post-operative period
A recent study has quantiﬁed the beneﬁt of goal directed
therapy in the immediate post-operative period using lithium
indicator dilution and pulse power analysis (LiDCO).3 Indeed, it istion of the displayed parameters see text).
Fig. 6. The LiDCO display shows that the fall in blood pressure (third trace down) at induction of anaesthesia (2) is entirely due to a proportional fall in cardiac output and SV (top
trace, y axis in l pm, bottom trace SV in mls). The second trace down shows a slight increase in systemic vascular resistance (SVR). This case was successfully treated with ephedrine
followed by a phenylephrine infusion. A pure vasoconstrictor, such as metaraminol, would have been inappropriate. (Display obtained after downloading the data using LiDCO-
ViewPro software).
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observed as predictors of good outcome.10–13 These major increases
in CO and DO2 have been necessitated as a response to less than
optimum DO2 intra-operatively and Shoemaker found that the
greater the deﬁcit in intra-operative DO2 the poorer the outcome.10
However, these deﬁcits may not be obligatory if CO, DO2, cerebral
and tissue oxygenation are maintained intra-operatively at pre-
operative values, alongside optimization of anaesthetic depth.
Our thesis is that to be truly effective, advanced monitoring
must be used throughout the peri-operative period to maximise the
improvement in patient outcome.5. Overview of some current advanced haemodynamic
monitors
In this brief review we will only consider those monitors which
are minimally invasive and can be easily utilized intra-operatively.
The review is not exhaustive and other monitors can also be used.5.1. Oesophageal Doppler monitor (ODM)
Non-invasive measurements of stroke volume, cardiac output
and ﬂuid responsiveness can be obtained by utilizing the principle
of Doppler shift. Velocity of blood ﬂowing in the descending
thoracic aorta is obtained by measuring the Doppler shift in
frequency of sound waves bounced off moving red blood cells. Thus
the ODM probe tip is positioned in the esophagus at a depth of
about 35–40 cm corresponding to the anatomical level T5/T6. The
sound wave frequency employed is set at 4 mHz. Cardiac output is
calculated by ﬁrstly estimating the diameter (and thence area) ofthe descending aorta from a normogram based on the patient’s age,
weight and height and then from the distance travelled by the
blood in unit time utilizing analysis of the Doppler velocity wave-
form (stroke distance, SD). This is averaged out over 5 cycles and an
average stroke volume (SV) obtained by multiplying aortic area by
the average SD. An additional 30% is added to this number on the
assumption that descending thoracic aortic blood ﬂow constitutes
only 70% of total cardiac output. ‘Peak Velocity’ is taken to be an
indication of contractility, and the ‘Corrected Flow Time, FTc’ to be
an indication of preload. Fluid responsiveness is determined by
assessing the effect of ﬂuid administration on FTc (ideally kept
between 350 and 450 m s) and the effect of ﬂuid challenges on
increase in SV.27,31,70
The basic advantage of this system is that it is non invasive
(although there is still the theoretical risk of esophageal trauma).
The disadvantages include difﬁculty in positioning the probe tip,
especially in the elderly patient where shifting of the probe tip over
time may lead to a sub-optimal trace in up to 20% of cases in the
authors’ experience. In addition there may be disparity between
cardiac outputs obtained with this monitor and others using
thermal dilution and partial carbon dioxide re-breathing tech-
niques to calculate cardiac output using the Fick principle (NICO,
Philips Respironics, Netherlands).235.2. The LiDCOplus and rapid
5.2.1. Introduction
The LiDCO system uses pulse contour power analysis (PulseCO)
of the radial artery pressure waveform to measure nominal SV and
thus CO.71,72 Lithium (c.f. dye) dilution is used to calibrate the
Fig. 7. Shows the effect of two vasoactive drugs, metaraminol (2) and ephedrine (4) on mean blood pressure (MAP, bottomrace) and cardiac output (CO, top trace) during
anaesthesia. It can be seen that metaraminol produces a short lived increase in MAP, which is purely due to an increased systemic vascular resistance (SVR, middle trace) and is
associated with a slight decline in CO, whereas ephedrine has a beneﬁcial effect on both MAP and CO with no change in SVR. (Display obtained after downloading the data using
LiDCOViewPro software).
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studies have been generally favorable in its ability to continuously
monitor SV.72–76 However, although some studies have questioned
the ability of LiDCO to track rapid changes in SV as a result of rapid
haemorrhage in animal models or use of vasoconstrictors or dila-
tors, the limits of agreement and reproducibility are almost always
within the criteria speciﬁed for such monitors.41
5.2.2. Use of LiDCO technology in the operating room
Although the LiDCOplus has been used very widely in the
Intensive Care environment and in the post-operative period to
optimize oxygen delivery,3 the perceived calibration difﬁculties
meant that it was little used in the operating room. Another issue
related to calibration difﬁculties due to Lithium electrode drift
immediately following the concomitant use of competitive neuro-
muscular blocking (NMB) drugs. This drift does not occur with the
phenylisoquinoline NMBs, atracurium and cisatracurium and is of
doubtful signiﬁcance.Fig. 8. The LiDCO display shows the fall in mean arterial pressure (MAP, bottom trace) from
vascular resistance (SVR, middle trace) with no change in cardiac output (CO, top trace). He
obtained after downloading the data using LiDCOViewPro software).However, the contention is that in most elective cases the
anaesthetist is (or should be) concerned with maintenance of pre-
operative values rather than needing to know the actual values in
the vast majority of patients. This can best be obtained by place-
ment of the radial arterial line prior to induction of anaesthesia to
obtain key baseline haemodynamic parameters. The fall in CO post
induction in 18 elderly patients following induction with remi-
fentanil and propofol is shown in Fig. 4 (authors’ data). The average
drop is 44% but usually recovers following commencement of
surgery. However, if monitoring commences post induction (as is
usually the case with the ODM) then the anaesthetist may falsely
assume that the CO measured at this time is the ‘‘baseline’’ value.
Maintenance of CO at this rather than the pre-operative value will
lead to decreased oxygen delivery during the procedure and result
in an oxygen debt which has to be repaid post-operatively.
Facilitation of the use of LiDCO technology in the operating
room, based on the issues raised above, has led to the development
of the LiDCOrapid. This has a much simpler interface and a more100 mm Hg to 60 mm Hg after induction (2) is due almost entirely to a fall in systemic
re either metaraminol or ephedrine, if deemed necessary, may be appropriate. (Display
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essential for patient optimization (Fig. 5). This includes nominal CO
and stroke volume (nCO and nSV) and SVV as well as screens to
follow the effects of surgical intervention, patient position and ﬂuid
and drug administration. nCO and nSV are determined by esti-
mating aortic capacitance from nomograms using the patient’s age,
weight and height.77 Unlike the LiDCOplus, there is no in-built
calibration system but one can enter externally validated cardiac
outputs. However, it is change – displayed by trends over time that
is probably more important.
Recent studies suggest that preload parameters displayed on
LiDCOrapid such as SVV over 10 min and change in Stroke Volume
(DSV) per beat are better indicators of ﬂuid status and ﬂuid
responsiveness than left ventricular end diastolic volume and
CVP.32,33,71,74 It is the ability to both measure and clearly display
SVV that makes the LiDCOrapid such a useful intra-operative
monitor in the absence of signiﬁcant dysrhythmia.
The ease of use and relevance of the displayed SVV, SV, CO and
SVR data make the new LiDCOrapid a useful addition to our
armamentarium of minimally invasive intra-operative haemody-
namic monitors.
Future developments should include the ability to incorporate
continuous oxygen content (from the Masimo Radical 7 Pulse
Oximeter) and thus DO2 and also the ability to transfer intra-
operative data to the post-operative high dependency environment
where high quality monitoring can then continue using another
LiDCOrapid monitor.
5.2.3. Use of the LiDCOplus and LiDCOrapid in the management of
intra-operative hypotension
Intra-operative management of hypotension is usually empirical
and involves the use of ﬂuids and vasoactive agents to increase
blood pressure. Use of the LiDCOrapid enables the effects of ﬂuid
administration on SV to be quantiﬁed and for the appropriate
selection of vasoactive drug. For instance, if a fall in MAP is due to
a reduction in CO (as is usually the case in the elderly) use of
a purely vasoconstrictor drug, such as metaraminol, is inappro-
priate and drugs that increase cardiac output, such as ephedrine or
phenylephrine, are preferred. Fig. 6 shows that a fall in MAP
(bottom trace) following induction of anaesthesia (mark 2) is
entirely due to a fall in CO as there is no fall in SVR. Treatment is by
ephedrine and phenylephrine bolus and infusion (3). This restores
both MAP and CO.
Fig. 7 shows the effect of two vasoactive drugs, metaraminol (2)
and ephedrine (4) on MAP and CO during anaesthesia. It can be
seen that metaraminol produces a short lived increase in MAP
which is purely due to an increased SVR and is associated with
a slight decline in CO, whereas ephedrine has a beneﬁcial effect on
both MAP and CO with no change in SVR.
In other situations, as in Fig. 8, the fall in MAP (bottom trace) from
100 mm Hg to 60 mm Hg after induction (2) may be due entirely to
a fall inSVR(middle trace)withnochange inCO(Toptrace).Hereeither
metaraminol or ephedrine, if deemed necessary, are appropriate.
5.2.4. Which monitor to use, LiDCOrapid or ODM?
At the time of writing there has been no head to head
comparison of the ODM and the LiDCOrapid devices and thus use
of one or other monitor is determined by the individual anaes-
thetist. We believe that the monitors are complementary to each
other. If it is felt that a radial arterial line should be inserted prior
to induction then the LiDCOrapid is the automatic choice with the
ODM reserved for those cases where an arterial line is not
needed.
Finally, while the review pays a lot of attention to preload and
SVR issues, it has not covered the requirement of assessingcontractility, especially in the very high risk patients who do not
respond to an increase in preload by increasing stroke volume. In
this regard transesophageal echocardiography (TOE) is superior to
the ODM due to both imaging and functional modalities. As TOE is
now increasingly recognized as a major tool in the assessment of
haemodynamic status in the ICUs and intra-operatively in cardiac
surgery, this technology should also be considered in major non-
cardiac surgery in selected cases.5.3. Decline in use of central venous catheterization for major
surgery
Use of the LiDCOrapid and ODM has resulted in a dramatic
reduction in the use of centrally placed venous catheters in high-
risk patients undergoing major peripheral vascular and abdominal
surgery. This reduces the risk of complications associated with the
use of these devices.28,78,79 Since CVP is no longer seen to be
a satisfactory measure to optimize ﬂuid administration, its use can
now be questioned intra-operatively except perhaps in cases of
hepatic resectionwhere it is also desirable to keep the CVP low.80 In
my own experience (DG) the use of triple lumen central lines in
major abdominal and vascular surgery has decreased from 85% to
5%, now being reserved solely for those patients with difﬁcult
peripheral venous access.5.4. Cost of implementation
There is a real cost to this high level monitoring and we are
entering a period of austerity in health care. However, a true cost
beneﬁt analysis of this technology is outside the scope of this
article. The cost of implementation of BIS monitoring in the USA
alone has been estimated at $360 m annually making it even more
important that we show that this technology (in combination with
other monitors) actually improves outcome.6. Conclusion
Haemodynamic and depth of anaesthesia monitors have
resulted in improvements in peri-operative management and
patient outcome. However, further beneﬁt may only be seen if
these monitors are used in combination (e.g. LiDCO (or ODM),
SCO and BIS). We also believe that the use of this intra-operative
technology must be extended to the immediate post-operative
period and funding must be identiﬁed to allow this to happen.
The requirement now is for the development of more highly
evolved and integrated monitors with smart screens where the
data captured is presented as organized and meaningful infor-
mation to the end user, whether anaesthetist, surgeon or nurse,
to inform appropriate interventions. This new generation of
monitors must also allow for the data to be archived and used
for informing further high quality clinical trials using this
technology.Conﬂict of interest statement
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